Prior authorization, step therapy and shifting coverage rules keep patients from obesity drugs with proven benefits, an endocrinologist argues — and the long-term savings make the case for broader access.
In 590,282 California heart attack hospitalizations, a new PCI-capable facility within a 30-minute drive lowered 30-day mortality 20% in communities without prior access but did not change survival where the procedure was already available.
An Oregon Health & Science University-led analysis of nearly 200,000 people found a 20% to 30% higher rate of fatty liver disease and cirrhosis among those who reported eating after dinner or after bedtime.